The article focuses on the condition of investments in the biotechnology industry in the U.S. For the past 25 years, stock exchanges played the pivotal role in making the country's biotech industry the world's largest. Venture capitalists and private equity investors are considered as the core of biotech financing. Secondary offerings also produced billions for this sector.